Shanghai Shyndec Pharmaceutical Co., Ltd.
Shanghai Shyndec Pharmaceutical Co., Ltd. is a registered legal entity registered in China under 310000000048680, and its current status with SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) is active. The company was incorporated on 1 January 1996 and lists its registered address as Shanghai, China. 3 shareholders are on record for Shanghai Shyndec Pharmaceutical Co., Ltd., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) and was last updated on 22 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
3
Three shareholders are currently on record for Shanghai Shyndec Pharmaceutical Co., Ltd., held on the capital contribution filing on the National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), filed under the Company Law of the PRC.
The largest of these is Vanguard International Stock Index-Emerging Markets Stk, holding 57.6% — a majority holding — followed by DFA Emerging Markets Core Equity Portfolio at 32.4%; the remaining 1 shareholder shown holds smaller stakes.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Vanguard International Stock Index-Emerging Markets Stk | 57.6% | SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) | |
| DFA Emerging Markets Core Equity Portfolio | 32.4% | SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) | |
| DFA Emerging Markets Small Cap Series | 9.9% | SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) |
Officers
5
The Vp & Financial Director of Shanghai Shyndec Pharmaceutical Co., Ltd. on record is Hao Li; 5 officers are shown here, filed with SAMR — public search via GSXT (National Enterprise Credit Information Publicity System).
The register reports 11 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at Shanghai Shyndec Pharmaceutical Co., Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Shanghai Shyndec Pharmaceutical Co., Ltd.?
Three shareholders are currently on record for Shanghai Shyndec Pharmaceutical Co., Ltd., held on the capital contribution filing on the National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), filed under the Company Law of the PRC. The largest of these is Vanguard International Stock Index-Emerging Markets Stk, holding 57.6% — a majority holding — followed by DFA Emerging Markets Core Equity Portfolio at 32.4%; the remaining 1 shareholder shown holds smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Shanghai Shyndec Pharmaceutical Co., Ltd.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Shanghai Shyndec Pharmaceutical Co., Ltd. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Shanghai Shyndec Pharmaceutical Co., Ltd. have on record?
3 shareholders are shown on record for Shanghai Shyndec Pharmaceutical Co., Ltd..
What is Shanghai Shyndec Pharmaceutical Co., Ltd.'s company registration number?
Shanghai Shyndec Pharmaceutical Co., Ltd.'s registration number is 310000000048680, filed with SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) in China. Its current status on the register is active.
Is Shanghai Shyndec Pharmaceutical Co., Ltd. still an active company?
Shanghai Shyndec Pharmaceutical Co., Ltd.'s status on SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) is listed as active.
When was Shanghai Shyndec Pharmaceutical Co., Ltd. incorporated?
Shanghai Shyndec Pharmaceutical Co., Ltd. was incorporated on 1 January 1996, according to SAMR — public search via GSXT (National Enterprise Credit Information Publicity System).
What is Shanghai Shyndec Pharmaceutical Co., Ltd.'s registered address?
The registered address on file for Shanghai Shyndec Pharmaceutical Co., Ltd. is Shanghai, China.
Who are the officers/directors of Shanghai Shyndec Pharmaceutical Co., Ltd.?
The Vp & Financial Director of Shanghai Shyndec Pharmaceutical Co., Ltd. on record is Hao Li; 5 officers are shown here, filed with SAMR — public search via GSXT (National Enterprise Credit Information Publicity System). Management authority at Shanghai Shyndec Pharmaceutical Co., Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Can Zavia monitor changes to Shanghai Shyndec Pharmaceutical Co., Ltd.'s ownership over time?
This profile reflects a point-in-time snapshot from SAMR — public search via GSXT (National Enterprise Credit Information Publicity System). Zavia's monitoring API can track changes to Shanghai Shyndec Pharmaceutical Co., Ltd.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Shanghai Shyndec Pharmaceutical Co., Ltd.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including China, so records like Shanghai Shyndec Pharmaceutical Co., Ltd.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) and was last synced on 22 September 2026.